Flow cytometric analysis of ca-induced membrane permeability transition of isolated rat liver mitochondria

Teruo Umegaki1, Yuya Okimura, Hirofumi Fujita

  • 1Department of Cytology & Histology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikatacho, Okayama 700-8558, Japan.

Insights

Calcium (Ca2+) induces mitochondrial permeability transition (MPT) by first generating reactive oxygen species (ROS), then causing depolarization, swelling, and Ca2+ release. Antioxidants and phospholipase A2 inhibitors block these MPT events.

Area of Science:

  • Mitochondrial biology
  • Cell death mechanisms
  • Biochemistry

Background:

  • Mitochondrial permeability transition (MPT) is crucial in apoptotic cell death.
  • Classic MPT involves Ca2+, phosphate, and substrates, leading to ROS, depolarization, swelling, and Ca2+ release.
  • The precise sequence of MPT events and antioxidant effects are not fully understood.

Purpose of the Study:

  • To elucidate the sequential events of calcium-induced MPT in mitochondria.
  • To investigate the role of reactive oxygen species (ROS) and antioxidants in MPT.
  • To explore the involvement of phospholipase A2 in MPT.

Main Methods:

  • Utilized flow cytometry for precise analysis of MPT events in isolated mitochondria.
  • Employed antioxidants like glutathione and N-acetylcysteine to assess their inhibitory effects.
  • Tested various inhibitors of calcium-induced phospholipase A2.

Main Results:

  • Flow cytometry demonstrated a sequential induction of ROS generation, depolarization, swelling, and Ca2+ release by Ca2+.
  • These Ca2+-induced events were sensitive to cyclosporine A and inhibited by antioxidants.
  • Inhibitors of Ca2+-induced phospholipase A2 effectively suppressed all observed MPT events.

Conclusions:

  • Calcium-induced MPT proceeds sequentially through ROS generation, depolarization, swelling, and Ca2+ release.
  • ROS generation and phospholipase A2 activation are key mechanisms initiating Ca2+-induced MPT.
  • Antioxidants and phospholipase A2 inhibitors offer potential therapeutic targets for modulating MPT.

Related Concept Videos